CytomX Therapeutics, Inc. Common Stock (CTMX)

Typically moves ±16.58% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

CytomX Therapeutics, Inc. Common Stock (CTMX) has reported earnings 21 times since Aug 05, 2021. The stock moves an average of ±16.58% the day after reporting, closing higher 61.9% of the time. Its largest post-earnings gain was +125.78% (May 12, 2025) and its largest decline was -51.43% (May 08, 2024). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How CTMX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±16.58%

Positive %

61.9%

Negative %

38.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☽ POST	+2.66%	open_in_new
May 07, 2026	☽ POST	-0.25%	open_in_new
Mar 16, 2026	☀ PRE	+44.02%	open_in_new
Nov 06, 2025	☽ POST	-13.69%	open_in_new
Aug 07, 2025	☽ POST	+12.92%	open_in_new
May 12, 2025	☀ PRE	+125.78%	open_in_new
Mar 06, 2025	☽ POST	+7.39%	open_in_new
Nov 07, 2024	☽ POST	+10%	open_in_new
Aug 08, 2024	☽ POST	+0.83%	open_in_new
May 08, 2024	☽ POST	-51.43%	open_in_new
Mar 11, 2024	☽ POST	-14%	open_in_new
Nov 07, 2023	☽ POST	-2.29%	open_in_new
Aug 08, 2023	☽ POST	-3.24%	open_in_new
May 09, 2023	☽ POST	+6.43%	open_in_new
Mar 27, 2023	☽ POST	-15.64%	open_in_new
Nov 08, 2022	☽ POST	+0%	open_in_new
Aug 04, 2022	☽ POST	+2.46%	open_in_new
May 05, 2022	☽ POST	+1.25%	open_in_new
Mar 01, 2022	☽ POST	+14.39%	open_in_new
Nov 04, 2021	☽ POST	+10.42%	open_in_new
Aug 05, 2021	☽ POST	-9.11%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±16.58%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 21 →

Funds holding

$202401475

Total value held

Buying

18 added · 3 reduced

Blackrock, Inc.

$65849333 +235.86%

Bank Of America Corp /De/

$56559813 +47.83%

State Street Corp

$44052135 +107.42%

Ubs Group Ag

$13006346 NEW BUY

Goldman Sachs Group Inc

$7513696 +37.25%

SEC Filing Types

description 4

10 chevron_right

description SCHEDULE 13G/A

7 chevron_right

description 8-K

4 chevron_right

description SCHEDULE 13G

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260807	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
S-8	20260806	open_in_new SEC.gov
3	20260805	open_in_new SEC.gov
4	20260805	open_in_new SEC.gov
SCHEDULE 13G	20260803	open_in_new SEC.gov
3	20260730	open_in_new SEC.gov

Frequently asked about CTMX earnings

When does CytomX Therapeutics, Inc. Common Stock report earnings next? expand_more

CytomX Therapeutics, Inc. Common Stock (CTMX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CTMX stock move after earnings? expand_more

Over 21 reports, CTMX has moved an average of ±16.58% the session after earnings, closing higher 61.9% of the time.

What was CTMX's biggest post-earnings move? expand_more

CTMX's largest post-earnings gain on record was +125.78% on May 12, 2025, and its largest decline was -51.43% on May 08, 2024.

Where can I find CytomX Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of CytomX Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.